TLR4 and breast cancer: This observation is in line with the general assumption that triple-negative is the most immunogenic BC subtype [3,32], and confirms a growing body of evidence underlining the pivotal role of TLR4 and pSTAT3 in the progression, metastasis, chemoresistance and immune evasion of triple-negative BC [33,34,35,36,37,38].